ExteNET_2A | R Documentation |
Kaplan-Meier digitized data from ExteNET, figure 2A (PMID 26874901). A reported sample size of 2,840 for a primary endpoint of iDFS in breast cancer.
ExteNET_2A
A data frame of 2,840 observations and 3 variables:
time | event time (in months) | |
event | DFS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (neratinib, placebo) | |
Chan A, Delaloge S, Holmes FA, et al. Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol 2016; 17: 367–77.
summary(ExteNET_2A)
kmplot(ExteNET_2A)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.